Analyze Diet

Equine giant cell tumor of soft parts: a series of 21 cases (2000-2007).

Abstract: In horses, giant-cell tumors of soft parts are rare neoplasms, with the majority of reported cases occurring within the hind limb muscles and soft tissues in older horses. The following article documents 21 cases of equine giant-cell tumors of soft parts clinically examined within the state of Colorado from 2000 to 2007. The majority of cases occurred in male horses aged 10 years or older. Nine (43%) arose within the hind limbs. Key histologic features included numerous multinucleated giant cells and hemosiderin-laden macrophages admixed with a spindle-cell proliferation. The majority demonstrated liposarcomatous change, variable areas of necrosis and hemorrhage, and an intermediate number of mitotic figures. Immunohistochemical results demonstrated 2 distinct cell populations: vimentin-expressing neoplastic mesenchymal cells and CD18 (histiocytic marker) expressing multinucleated giant cells. These results suggest a mesenchymal origin of the neoplasm with possible recruitment of the secondary histiocytic population. Surgical excision was attempted in the majority of horses and was considered clinically complete. A recurrence of the neoplasm was documented in 1 horse and 1 mule. In 18 horses, surgical excision, regardless of margin integrity, appeared successful with no recurrence of disease documented. Unfortunately, 10 of 21 horses were lost to follow-up within approximately 3 months of surgery. Of the 11 remaining horses that were available for follow-up evaluation, there has been no evidence of metastasis. A larger case series with more controlled follow-up is necessary to evaluate malignant potential and the importance of complete surgical excision.
Publication Date: 2008-07-05 PubMed ID: 18599861DOI: 10.1177/104063870802000418Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study investigates giant-cell tumors in horses, a rare condition mostly found in the hind limb tissues of older horses. The study, conducted in Colorado from 2000 to 2007, tracked 21 cases, noting occurrences particularly in male horses aged 10 years or more. The tumors displayed specific markers suggesting their origin and the effectiveness of surgical removal was also evaluated.

Research Subjects

  • The study focused on 21 documented cases of equine giant-cell tumors.
  • Most cases occurred in male horses aged 10 years or older, suggesting the condition is more common in older male horses.
  • Nearly half of the tumors (43%) were found within the hind limbs, indicating these areas as the most probable for tumor development.

Characteristics of Tumors

  • The tumors displayed key histological features such as multinucleated giant cells and hemosiderin-laden macrophages mixed with spindle-cell proliferation.
  • Most tumors indicated changes related to liposarcoma, variable areas of necrosis and hemorrhage, and intermediate numbers of mitotic figures.

Origins of Tumors

  • Immunohistochemical results suggested two distinct cell populations within the tumors: vimentin-expressing neoplastic mesenchymal cells and CD18 (a histiocytic marker) expressing multinucleated giant cells.
  • These results imply that the tumors originate from mesenchymal tissues with possible recruitment of a secondary histiocytic population.

Treatment and Follow-up

  • Surgical excision was attempted for most horses and in most cases was considered clinically complete.
  • A recurrence of the tumor was reported in one horse and one mule after surgery.
  • In 18 horses, surgery appeared successful with no recurrence of the tumor, regardless of whether all tumor margins were removed.
  • Unfortunately, nearly half the horses (10 out of 21) could not be followed-up within approximately 3 months after surgery, hindering the evaluation of long term outcomes.
  • Out of the 11 horses that were available for follow-up, none showed evidence of metastasis.

Future Research

  • The authors suggest that a larger study with controlled follow-up is needed to better understand the potential malignancy of these tumors and the importance of complete surgical excision.

Cite This Article

APA
Bush JM, Powers BE. (2008). Equine giant cell tumor of soft parts: a series of 21 cases (2000-2007). J Vet Diagn Invest, 20(4), 513-516. https://doi.org/10.1177/104063870802000418

Publication

ISSN: 1040-6387
NlmUniqueID: 9011490
Country: United States
Language: English
Volume: 20
Issue: 4
Pages: 513-516

Researcher Affiliations

Bush, Jamie M
  • Colorado State University, Veterinary Diagnostic Laboratory, Fort Collins, CO 80523, USA. Jamie.Bush@ColoState.edu
Powers, Barbara E

    MeSH Terms

    • Animals
    • Female
    • Giant Cell Tumors / pathology
    • Giant Cell Tumors / veterinary
    • Horse Diseases / pathology
    • Horses
    • Immunohistochemistry / veterinary
    • Male
    • Soft Tissue Neoplasms / pathology
    • Soft Tissue Neoplasms / veterinary
    • Time Factors

    Citations

    This article has been cited 1 times.
    1. Zimmerman K, Almy F, Saunders G, Crisman M, Leonardi L. An unusual case of giant cell tumor of soft parts in an American Warmblood horse.. Open Vet J 2019 Apr;9(1):44-48.
      doi: 10.4314/ovj.v9i1.8pubmed: 31086765google scholar: lookup